USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Department Of Biotechnology

USPTO PatentsView assignee record - 26 granted patents across 25 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

10.7

Avg claims per patent

+60%

5-year filing velocity

The verdict

Department holds 26 US patents across 25 technology areas, rank #11,626 of 50,000 tracked assignees.

#11,626
of 50,000 US assignees by volume: Top 38%
by Innovation Score (39.4/100): 10.7
avg claims per patent: +60%
filing velocity, last 5 yrs

Portfolio overview

Department Of Biotechnology has been granted 26 US utility patents between 2015 and 2024, placing Department Of Biotechnology at rank #11,626 across all assignees tracked by PlainPatent. This portfolio spans 25 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.7 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a Foreign Corporation, Department Of Biotechnology is one of the more focused assignees in the PatentsView dataset. By volume, Department sits between Dorma Deutschland Gmbh (26 patents, rank #11,622) and Eiken Kagaku Kabushiki Kaisha (26 patents, rank #11,630) - the closest US assignees by grant volume. The composite Innovation Score of 39.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 16 grants, compared with 10 in the 2015–2019 window, a +60% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Department Of Biotechnology's 10.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 25 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Department Of Biotechnology against peers pursuing similar technology classes.

Dorma Deutschland

26
DOT Incorporation

26
Darkvision

26
Davol

26
Design Infini

26
Ecobee

26
Efficient Energy

26
Eiken Kagaku

26
Department of Bio… ◀

26

What this shows Department holds 26 patents at rank #11,626, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Department

By rank, the assignees closest to #11,626 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Department's primary technology class.

Department's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Department Of Biotechnology patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	7.7%
2017	2	7.7%
2018	3	11.5%
2019	3	11.5%
2021	9	34.6%
2022	2	7.7%
2023	2	7.7%
2024	3	11.5%

Which technologies does Department Of Biotechnology patent most?

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 14

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 13

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 9

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 8

C12Y - ENZYMES 4

C07K - PEPTIDES 4

C08H - DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS 3

D21B - FIBROUS RAW MATERIALS OR THEIR MECHANICAL TREATMENT 2

D21C - PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

C13K - SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES 1

C07G - COMPOUNDS OF UNKNOWN CONSTITUTION 1

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 1

B01D - SEPARATION 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

Top 15 of 25 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Simple

Velocity Accelerating

Where it ranks

Overall rank by patents

#11,626

Across all tracked assignees

Innovation Score

39.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Department Of Biotechnology hold?

Department Of Biotechnology holds 26 US granted patents filed between 2015 and 2024, spanning 25 technology areas.

What is Department Of Biotechnology's Innovation Score?

Department Of Biotechnology has an Innovation Score of 39.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Department Of Biotechnology focus on?

Department Of Biotechnology's top technology area is C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE) with 14 patents. The company has filed patents in 25 CPC subclasses total.

Is Department Of Biotechnology's patent filing rate increasing or decreasing?

Department Of Biotechnology's recent filing velocity is +60% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Department Of Biotechnology's patents?

Department Of Biotechnology's patents average 10.7 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Department Of Biotechnology patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Department's 26 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Department ranks #11,626 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12P - see who else leads that technology area. C12P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.